A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
